Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesMyeloma Bone Disease: Recent Advances in Biology, Diagnosis, and Treatment
The Oncologist, 04/03/09
Sezer O - The review focuses on recent advances in understanding of the biology of osteoclast activation and osteoblast inhibition in MM, diagnostic standards, and recent progress in treatment options for myeloma bone disease. Translational research has enabled a rapid transfer of mechanistic insights from the bench to the bedside and will hopefully result in better treatment options and outcome for patients in near future.
Related Articles
Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells
British Journal of Haematology, 11/23/09
Relevance Score: 80%
Mikuliczs disease with severe thrombocytopenia following autologous stem cell transplantation in a multiple myeloma patient
International Journal of Hematology, 10/30/09
Relevance Score: 79%
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial : The Lancet Oncology
The Lancet Oncology - Online First, 10/23/09
Relevance Score: 79%
Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells
British Journal of Haematology, 10/16/09
Relevance Score: 79%
Combined Histocompatibility Leukocyte Antigenmatched Donor Bone Marrow and Renal Transplantation for Multiple Myeloma With End Stage Renal Disease: the Induction of Allograft Tolerance Through Mixed Lymphohematopoietic Chimerism
Transplantation, 10/08/09
Relevance Score: 79%
Today in Bone/Cartilage...keeping you current
Receive free subspecialty "5-minute updates" via email
Noninvasive Prediction of Fracture Risk in Patients with Metastatic Cancer to the Spine
Clinical Cancer Research, 12/15/09
Antitumor Efficacy of Two Novel Non-Thiazolidinedione Compounds as Peroxisome Proliferator-Activated Receptor-gamma Agonists in Human Osteosarcoma Cells in vitro
Chemotherapy, 12/11/09
EWS/FLI and Its Downstream Target NR0B1 Interact Directly to Modulate Transcription and Oncogenesis in Ewing's Sarcoma
Cancer Research, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor